XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statement Of Cash Flows
 9 Months Ended
Mar. 31, 2021
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (29,637,673)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in value of warrant liabilities 27,563,109
Transaction costs incurred in connection with warrant liabilities 511,177
Interest earned on marketable securities held in Trust Account (32,396)
Changes in operating assets and liabilities:  
Prepaid expenses (25,816)
Accrued expenses 601,749
Net cash used in operating activities (1,019,850)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (254,350,000)
Net cash used in investing activities (254,350,000)
Cash Flows from Financing Activities:  
Proceeds from sale of Units, net of underwriting discounts paid 249,263,000
Proceeds from sale of Private Placement Warrants 6,837,000
Proceeds from promissory note – related party 150,000
Repayment of promissory note – related party (150,000)
Payment of offering costs (423,527)
Net cash provided by financing activities 255,676,473
Net Change in Cash 306,623
Cash – Beginning of period 0
Cash – End of period 306,623
Non-Cash investing and financing activities:  
Initial classification of Class A common stock subject to possible redemption 227,864,037
Change in value of Class A common stock subject to possible redemption (27,563,109)
Deferred underwriting fee payable 8,902,250
Offering costs paid by Sponsor in exchange for issuance of Founder Shares $ 25,000